Terms: = Endocrine gland cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Treatment
105 results:
1. A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer.
Zhu SL; Qi M; Chen MT; Lin JP; Huang HF; Deng LJ; Zhou XW
Phytomedicine; 2024 Jun; 128():155377. PubMed ID: 38503154
[TBL] [Abstract] [Full Text] [Related]
2. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
3. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting sox2/MYC signaling and restoring chemosensitivity.
Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C
J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687
[TBL] [Abstract] [Full Text] [Related]
4. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis.
Wang F; Zhang Y; Pang R; Shi S; Wang R
Acta Pharm; 2023 Sep; 73(3):475-488. PubMed ID: 37708956
[TBL] [Abstract] [Full Text] [Related]
5. Vemurafenib activates the sonic hedgehog pathway and promotes thyroid cancer stem cell self-renewal.
Lu Y; Zhao Y; Liu P; Xu X
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37643458
[TBL] [Abstract] [Full Text] [Related]
6. Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells.
Wang H; Liu Y; Wang Y; Xu T; Xia G; Huang X
Cancer Med; 2023 Jul; 12(14):15277-15288. PubMed ID: 37409635
[TBL] [Abstract] [Full Text] [Related]
7. Primary Ovarian Small Cell Carcinoma of Pulmonary Type: Analysis of 6 Cases and Review of 31 Cases in the Literatures.
Chen X; Liu HL; Wang JS; Zhao FH
Chin Med Sci J; 2023 Jun; 38(2):130-137. PubMed ID: 37286512
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating the biological effectiveness of boron neutron capture therapy by using microfluidics-based pancreatic tumor spheroids.
Yu LY; Hsu CH; Li CY; Hong SY; Chen CR; Chen CS
Analyst; 2023 Jun; 148(13):3045-3056. PubMed ID: 37272284
[No Abstract] [Full Text] [Related]
9. METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.
Chen J; Zhang H; Xiu C; Gao C; Wu S; Bai J; Shen Q; Yin T
Cancer Lett; 2023 Jul; 565():216222. PubMed ID: 37196908
[TBL] [Abstract] [Full Text] [Related]
10. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
11. Regulation of self-renewal in ovarian cancer stem cells by fructose via chaperone-mediated autophagy.
Sohn EJ; Kim JH; Oh SO; Kim JY
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166723. PubMed ID: 37087023
[TBL] [Abstract] [Full Text] [Related]
12. Low-dose BPA and its substitute BPS promote ovarian cancer cell stemness via a non-canonical PINK1/p53 mitophagic signaling.
Yuan X; Chen K; Zheng F; Xu S; Li Y; Wang Y; Ni H; Wang F; Cui Z; Qin Y; Xia D; Wu Y
J Hazard Mater; 2023 Jun; 452():131288. PubMed ID: 36989771
[TBL] [Abstract] [Full Text] [Related]
13. Reactivated thyroid hormone receptor β attenuates anaplastic thyroid cancer (ATC) stem cell activity.
Zhu X; Zhao L; Doolittle WKL; Cheng SY
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36939877
[TBL] [Abstract] [Full Text] [Related]
14. Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells.
Yuan L; Li P; Li J; Peng J; Zhouwen J; Ma S; Jia G; Jia W; Kang P
Acta Neuropathol Commun; 2023 Feb; 11(1):24. PubMed ID: 36750863
[TBL] [Abstract] [Full Text] [Related]
15. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
16. TWEAK-Fn14-RelB Signaling Cascade Promotes Stem Cell-like Features that Contribute to Post-Chemotherapy Ovarian cancer Relapse.
Holmberg R; Robinson M; Gilbert SF; Lujano-Olazaba O; Waters JA; Kogan E; Velasquez CLR; Stevenson D; Cruz LS; Alexander LJ; Lara J; Mu EM; Camillo JR; Bitler BG; Huxford T; House CD
Mol Cancer Res; 2023 Feb; 21(2):170-186. PubMed ID: 36214671
[TBL] [Abstract] [Full Text] [Related]
17. NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells.
Yun H; Han GH; Kim J; Chung JY; Kim JH; Cho H
J Cell Mol Med; 2022 Oct; 26(20):5277-5291. PubMed ID: 36114703
[TBL] [Abstract] [Full Text] [Related]
18. Prolyl 4-hydroxylase P4HA1 Mediates the Interplay Between Glucose Metabolism and Stemness in Pancreatic cancer Cells.
Cao X; Cao Y; Zhao H; Wang P; Zhu Z
Curr Stem Cell Res Ther; 2023; 18(5):712-719. PubMed ID: 36043766
[TBL] [Abstract] [Full Text] [Related]
19. Therapeutic Targeting of Ovarian cancer Stem Cells Using Estrogen Receptor Beta Agonist.
He Y; Alejo S; Venkata PP; Johnson JD; Loeffel I; Pratap UP; Zou Y; Lai Z; Tekmal RR; Kost ER; Sareddy GR
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806169
[TBL] [Abstract] [Full Text] [Related]
20. In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and sox2.
du Manoir S; Delpech H; Orsetti B; Jacot W; Pirot N; Noel J; Colombo PE; Sardet C; Theillet C
J Pathol; 2022 Jul; 257(3):367-378. PubMed ID: 35302657
[TBL] [Abstract] [Full Text] [Related]
[Next]